A W Tolcher

Author PubWeight™ 11.04^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.	Blood	1997	1.85
2	Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.	Ann Oncol	2009	1.33
3	Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer.	Br J Cancer	2011	0.99
4	Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.	J Clin Oncol	1996	0.98
5	A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.	Clin Cancer Res	2001	0.93
6	Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.	Cancer Chemother Pharmacol	2010	0.93
7	A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer.	Ann Oncol	2005	0.88
8	Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity.	Ann Oncol	2004	0.87
9	Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection.	J Pharm Biomed Anal	1997	0.82
10	Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: inference for in vitro assays.	In Vitro Cell Dev Biol	1987	0.78
11	BR96-doxorubicin: been there, done that!	J Clin Oncol	2000	0.75
12	In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents.	Cancer Chemother Pharmacol	1990	0.75
13	Paclitaxel administration using portable infusion pumps.	J Clin Oncol	1993	0.75